Chelsea Kotch, MD, MSCE

female silhouette icon
Chelsea Kotch, MD, MSCE, is an attending physician and Instructor with the Division of Oncology at Children's Hospital of Philadelphia.

Locations: Main Hospital
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training


Residency - Pediatrics, Johns Hopkins Hospital, Baltimore, MD


Fellowship - Pediatric Hematology/Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA

Fellowship - Pediatric Neuro-Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA

Graduate Degree

MSCE - Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA

Titles and Academic Titles

Instructor and Attending Physician

Conditions Treated

Departments and Services

Research Interests

Neurofibromatosis-associated tumors of childhood




Kotch C, Avery R, Getz KD, et al. Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1 [published online ahead of print, 2022 Jan 9]. Neuro Oncol. 2022;noac013. doi:10.1093/neuonc/noac013


Kotch C, Friedman DF, Wilkins BJ, et al. “Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities”. Pediatrics, 2021;147(2):e20193367

Zhao X, Kotch C, Fox E, et al. “NTRK Fusions Identified in 1,217 Pediatric Tumors: the Frequency, Fusion Partners, and Clinical Outcome”. JCO Precision Oncology, 2021:5 204-214


Fundora J, Kotch C, Serwint J. “A 7-month-old with fever and facial palsy”. Pediatrics In Review. Pediatrics in Review, October 2020, 41 (Supplement 1) S30-S32


Matesanz S, Kotch C, Perrone C, et al. “Expanding the MOG phenotype: Brainstem Encephalitis with Punctate and Curvilinear Enhancement”, Neurology: Neuroimmunology & Neuroinflammation, 2019 Nov, 6 (6) e619

Kotch C, Barrett D & Teachey DT. “Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome”, Expert Review of Clinical Immunology, 2019 Jun 20:1-10.



Kotch C, Avery RA, et al. “Predictors of Early Treatment-Refractory and Relapsed Optic Pathway Glioma”. Children’s Tumor Foundation NF Virtual Conference, June 2021. (Platform presentation)

Kotch C, Fisher MJ, Zhong Y, Gallo D, Fan E, Lin F, Chen J, Santi M, & Li MM. “Atypical Teratoid Rhabdoid Tumor in a Child With Neurofibromatosis Type 2: A Novel Dual Diagnosis” [Abstract]. In: Proceedings of the 2021 Annual Clinical Genetics Meeting, Virtual: ACMG; 2021, Abstract nr eP058 (Poster presentation)



Kotch, C & Hogarty, M (2021). Langerhans Cell Histiocytosis and Diabetes Insipidus. In C Alter (Ed.), Diabetes Insipidus: A Pocket Guide, Springer Nature. Accepted, In production

Mcglynn, J & Kotch, C (2021). Hemostasis & Thrombosis. In R. Tenney-Soeiro (Ed.), Netter’s Pediatrics, 2nd Edition, Philadelphia: Elsevier. Accepted, In production


Kotch, CS & Yusuf, Z. (2015). Oncology. In H. Hughes & L. Kahl (Ed.), The Harriet Lane Handbook, 21st Edition  (pp. 523-542). Philadelphia: Elsevier.

Awards and Honors

2021, Neurofibromatosis Young Investigators Forum Travel Award
2021. Academic Enrichment Fund Award

Leadership and Memberships

2020-present, American Society of Pediatric Hematology/Oncology
2019-present, Society for Neuro-Oncology
2017-present, Children’s Oncology Group